title: Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee.
abstract: BACKGROUND
  A unique form of lead failure has been described in the Riata (8-F) and Riata ST (7-F) silicone defibrillation lead degradation of the outer insulation, resulting in the externalization of conductor cables.
  
  
  OBJECTIVE
  To assess rates of lead revision due to lead failure in Riata leads affected by the Riata advisory.
  
  
  METHODS
  Nineteen implantable cardioverter-defibrillator implant and follow-up centers were surveyed.
  
  
  RESULTS
  As of March 1, 2012, there were 5043 known affected leads implanted in Canada. Data on 4358 (86.4%) leads were obtained; 65.3% of these were Riata (8-F) and 32.4% were Riata ST (7-F) leads. The median time from implant to last follow-up was 5 years. Electrical abnormalities were reported in 4.6% of the affected leads; 8.0% of these were found to have concomitant radiographic evidence of externalization. The rate of electrical failure was higher in the 8-F (5.2%) vs 7-F (3.3%) leads (P = .007). Oversensing with or without inappropriate shocks was reported in 39.8% of the leads with confirmed failure. Abnormally high or low impedance values (29.9%) and elevated pacing capture thresholds (43.8%) were frequently reported. One death (0.5%) attributed to lead failure was reported. Among the leads that were replaced, 21% were extracted. Two major complications (1.0%) were attributed to extraction of these leads.
  
  
  CONCLUSIONS
  The overall rate of lead failure in the Riata (8-F) and Riata ST (7-F) leads is higher than previously reported by using passive surveillance data. The impact of recent advisories related to these leads is not yet apparent.
authors: QEII Health Sciences Centre, Halifax, Nova Scotia, Canada. parkashr@cdha.nshealth.ca
authors: Ratika
authors: R
authors: Parkash
authors: Derek
authors: D
authors: Exner
authors: Jean
authors: J
authors: Champagne
authors: Iqwal
authors: I
authors: Mangat
authors: Bernard
authors: B
authors: Thibault
authors: Jeffrey S
authors: JS
authors: Healey
authors: Stanley
authors: S
authors: Tung
authors: Eugene
authors: E
authors: Crystal
authors: Christopher
authors: C
authors: Simpson
authors: Pablo B
authors: PB
authors: Nery
authors: Laurence
authors: L
authors: Sterns
authors: Sean
authors: S
authors: Connors
authors: Doug
authors: D
authors: Cameron
authors: Atul
authors: A
authors: Verma
authors: Marianne
authors: M
authors: Beardsall
authors: Kevin
authors: K
authors: Wolfe
authors: Vidal
authors: V
authors: Essebag
authors: Felix
authors: F
authors: Ayala-Paredes
authors: Shubhayan
authors: S
authors: Sanatani
authors: Benoit
authors: B
authors: Coutu
authors: Jennifer
authors: J
authors: Fraser
authors: Satish
authors: S
authors: Toal
authors: Francois
authors: F
authors: Philippon
authors: Anthony S L
authors: AS
authors: Tang
authors: Raymond
authors: R
authors: Yee
authors: Andrew
authors: A
authors: Krahn
mesh_terms: D002170:Canada; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D004567:Electrodes, Implanted / Q000009:adverse effects* / Q000706:statistics & numerical data; D019544:Equipment Failure Analysis / Q000379:methods*; D006801:Humans; D011475:Prosthesis Failure; D011795:Surveys and Questionnaires